Gap cuts sales outlook after Old Navy drop
Gap (NYSE:GAP) lowered its full-year 2026 net sales growth forecast after Old Navy reported weaker-than-expected second-quarter results, with company revenue declining 2% to $3.65 billion.
Every story in this section, newest first — page 73 of 373.
Gap (NYSE:GAP) lowered its full-year 2026 net sales growth forecast after Old Navy reported weaker-than-expected second-quarter results, with company revenue declining 2% to $3.65 billion.
United Therapeutics (NASDAQ:UTHR) announced eight presentations at the 2026 European Society of Cardiology and European Respiratory Society congresses covering investigational therapies for pulmonary arterial hypertension and other lung diseases.
iBio (NASDAQ:IBIO) reported fiscal 2026 results as it advanced into clinical-stage development, with its Phase 1 trial of IBIO-600 progressing after 31 of 32 participants were dosed across four cohorts.
Eli Lilly (NYSE:LLY) received U.S. FDA approval for an expanded indication of Mounjaro (tirzepatide) to reduce the risk of major adverse cardiovascular events in adults with type 2 diabetes at high cardiovascular risk.
Altria Group (NYSE:MO) appointed Steven W. Presley to its Board of Directors effective August 27, 2026, adding a director with experience in food and beverage operations.
Caleres (NYSE:CAL) announced that its Board of Directors declared a regular quarterly cash dividend of $0.07 per share, payable on September 25, 2026.
Dollar General (NYSE:DG) announced that Executive Vice President and General Counsel Rhonda Taylor will retire from the company, with Kelly Collier appointed as her successor effective December 7, 2026.
Range Resources (NYSE:RRC) announced that its Board of Directors declared a third-quarter 2026 quarterly cash dividend of $0.10 per common share.
Jiayin Group (NASDAQ:JFIN) reported second-quarter 2026 net revenue of RMB736.9 million, down 60.9% year over year, as transaction volume declined to RMB9.5 billion from the prior-year period.
Quoin Pharmaceuticals (NASDAQ:QNRX) reported positive interim results from its Phase 2/3 CL-QRX003-004 study showing QRX003 4% lotion met its primary endpoint in the first six participants with Netherton Syndrome.
MINISO Group (NYSE:MNSO) reported first-half 2026 revenue of RMB11,498.9 million, up 22.4% year over year, as gross profit increased to RMB5,093.7 million and its global store network expanded.
Oil prices declined Friday as Brent crude futures fell to $89.10 per barrel and West Texas Intermediate futures dropped to $82.89, putting both benchmarks on track for weekly losses.
HUTCHMED (NASDAQ:HCM) received conditional approval from China’s National Medical Products Administration for ATLED® (fanregratinib, HMPL-453), an oral FGFR 1/2/3 inhibitor for certain adults with advanced intrahepatic cholangiocarcinoma.
BW LPG (NYSE:BWLP) reported second-quarter 2026 profit attributable to equity holders of $120 million, or $0.79 per share, supported by shipping performance and higher market activity.
Hafnia (NYSE:HAFN) reported second-quarter 2026 net profit of $277.8 million, or $0.56 per share, compared with $75.3 million, or $0.15 per share, in the prior-year quarter as tanker earnings increased.
Macy’s (NYSE:M) announced that its Board of Directors declared a regular quarterly dividend of 19.15 cents per share on the company’s common stock.
KKR (NYSE:KKR) agreed to pay a $250 million civil penalty to settle U.S. Department of Justice allegations that it failed to comply with pre-merger filing requirements in at least 16 transactions.
Canadian Imperial Bank of Commerce (NYSE:CM) reported fiscal third-quarter 2026 net income of C$2.41 billion, or C$2.47 per diluted share, as revenue increased 15% year over year to C$8.37 billion.
Hyperliquid Strategies (NASDAQ:PURR) reported fiscal 2026 results with net income of $305.5 million, driven mainly by unrealized gains on HYPE tokens as the company expanded its digital asset treasury platform.
AstraZeneca (NASDAQ:AZN) and Amgen (NASDAQ:AMGN) reported Phase III CROSSING trial results showing TEZSPIRE® (tezepelumab-ekko) achieved statistically significant improvements in eosinophilic esophagitis outcomes, with benefits maintained through week 52.
Pearl Diver Credit Company (NYSE:PDCC) reported second-quarter 2026 results with net asset value per common share rising to $11.15 from $10.48 as of March 31, 2026, while GAAP net income reached $8.5 million.
Aviat Networks (Nasdaq:AVNW) reported fiscal 2026 fourth-quarter revenue of $120.9 million, up 4.8% year over year, as annual revenue increased to $439.7 million and backlog reached $367 million.
Lucky Strike Entertainment (NYSE:LUCK) reported fiscal 2026 revenue of $1.25 billion, up 3.7% year over year, as the location-based entertainment company expanded its portfolio while reporting lower profitability.
Youxin Technology (NASDAQ:YAAS) reported unaudited first-half fiscal 2026 revenue of $1.88 million, up 444% year over year, mainly due to the consolidation of Celnet and higher customized CRM development activity.
Got a second for a cookie? 🍪Essential cookies keep Grafa running smoothly. A few optional ones help us see what's working so we can make it better. You're in control — change your mind any time. Cookie policy · Privacy policy